{"id":450501,"date":"2021-03-04T07:33:33","date_gmt":"2021-03-04T12:33:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=450501"},"modified":"2021-03-04T07:33:33","modified_gmt":"2021-03-04T12:33:33","slug":"provention-bio-to-present-at-two-upcoming-virtual-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/","title":{"rendered":"Provention Bio to Present at Two Upcoming Virtual Investor Conferences"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n

\n

\n RED BANK, N.J.<\/span>, March 4, 2021<\/span> \/PRNewswire\/ —\u00a0Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in two upcoming virtual investor conferences in March.<\/p>\n

\n

\n
\n \"(PRNewsfoto\/Provention
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n H.C. Wainwright Global Life Sciences Conference <\/b>\n <\/p>\n

\n Andrew Drechsler<\/span>, Provention Bio’s Chief Financial Officer will provide a corporate update at the H.C. Wainwright Global Life Sciences Conference.\u00a0 The webcast will be available beginning Tuesday, March 9, 2021<\/span>, at 7:00 am<\/span> E.T and can be accessed by visiting the Events and Webcasts section of the Company’s website: http:\/\/investors.proventionbio.com\/events<\/a>.<\/p>\n

\n Oppenheimer & Co. 31st Annual Healthcare Conference <\/b>\n <\/p>\n

Additionally, the company announced that Ashleigh Palmer<\/span>, Provention Bio’s Chief Executive Officer and Co-Founder will participate in a fireside chat presentation at the Oppenheimer & Co. 31st Annual Healthcare Conference on Tuesday, March 16, 2021<\/span> at 1:10 pm E.T.<\/span> The fireside chat will be webcast live and can be accessed by visiting the Events and Webcasts section of the Company’s website:\u00a0http:\/\/investors.proventionbio.com\/events<\/a>. <\/p>\n

Both webcasts will be archived on the Company’s website for 30 days following the presentation.<\/p>\n

\n About Provention Bio, Inc.: <\/b>\n <\/p>\n

Provention Bio, Inc. (Nasdaq: PRVB) is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Biologics License Application (BLA) for teplizumab, its lead investigational drug candidate, for the delay or prevention of clinical type 1 diabetes in at-risk individuals, has been filed by the U.S. Food and Drug Administration (FDA). The Company’s pipeline includes additional clinical-stage product candidates that have demonstrated in pre-clinical or clinical studies proof-of-mechanism and\/or proof-of-concept in other autoimmune diseases, including celiac disease and lupus. Visit www.ProventionBio.com<\/a>\u00a0for more information and follow us on Twitter: @ProventionBio.<\/p>\n

\n Internet Posting of Information:<\/b>\n <\/p>\n

Provention Bio, Inc. uses its website,\u00a0www.proventionbio.com<\/a>, as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Such disclosures will be included on the Company’s website in the “News” section. Accordingly, investors should monitor this portion of the Company’s website, in addition to following its press releases,\u00a0SEC\u00a0filings and public conference calls and webcasts.<\/p>\n

\n Investor Contacts:
<\/b>
\n Robert Doody<\/span>, VP of Investor Relations
rdoody@proventionbio.com<\/a>
<\/u>484-639-7235<\/p>\n

\n Sam Martin<\/span>, Argot Partners
sam@argotpartners.com<\/a><\/u> \u00a0
212-600-1902<\/p>\n

\n Media Contact:<\/b>
\n
\n Lori Rosen<\/span>, LDR Communications
lori@ldrcommunications.com<\/a>
<\/u>917-553-6808<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences-301240159.html<\/a><\/p>\n

SOURCE Provention Bio, Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire RED BANK, N.J., March 4, 2021 \/PRNewswire\/ —\u00a0Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in two upcoming virtual investor conferences in March. H.C. Wainwright Global Life Sciences Conference Andrew Drechsler, Provention Bio’s Chief Financial Officer will provide a corporate update at the H.C. Wainwright Global Life Sciences Conference.\u00a0 The webcast will be available beginning Tuesday, March 9, 2021, at 7:00 am E.T and can be accessed by visiting the Events and Webcasts section of the Company’s website: http:\/\/investors.proventionbio.com\/events. Oppenheimer & Co. 31st Annual Healthcare Conference Additionally, the company announced that Ashleigh Palmer, Provention Bio’s Chief Executive Officer and Co-Founder will participate in a fireside … <\/p>\n

Continue reading “Provention Bio to Present at Two Upcoming Virtual Investor Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-450501","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nProvention Bio to Present at Two Upcoming Virtual Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Provention Bio to Present at Two Upcoming Virtual Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire RED BANK, N.J., March 4, 2021 \/PRNewswire\/ —\u00a0Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in two upcoming virtual investor conferences in March. H.C. Wainwright Global Life Sciences Conference Andrew Drechsler, Provention Bio’s Chief Financial Officer will provide a corporate update at the H.C. Wainwright Global Life Sciences Conference.\u00a0 The webcast will be available beginning Tuesday, March 9, 2021, at 7:00 am E.T and can be accessed by visiting the Events and Webcasts section of the Company’s website: http:\/\/investors.proventionbio.com\/events. Oppenheimer & Co. 31st Annual Healthcare Conference Additionally, the company announced that Ashleigh Palmer, Provention Bio’s Chief Executive Officer and Co-Founder will participate in a fireside … Continue reading "Provention Bio to Present at Two Upcoming Virtual Investor Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-04T12:33:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/720849\/Provention_Bio_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Provention Bio to Present at Two Upcoming Virtual Investor Conferences\",\"datePublished\":\"2021-03-04T12:33:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\\\/\"},\"wordCount\":421,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/720849\\\/Provention_Bio_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\\\/\",\"name\":\"Provention Bio to Present at Two Upcoming Virtual Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/720849\\\/Provention_Bio_Logo.jpg\",\"datePublished\":\"2021-03-04T12:33:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/720849\\\/Provention_Bio_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/720849\\\/Provention_Bio_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Provention Bio to Present at Two Upcoming Virtual Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Provention Bio to Present at Two Upcoming Virtual Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Provention Bio to Present at Two Upcoming Virtual Investor Conferences - Market Newsdesk","og_description":"PR Newswire RED BANK, N.J., March 4, 2021 \/PRNewswire\/ —\u00a0Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in two upcoming virtual investor conferences in March. H.C. Wainwright Global Life Sciences Conference Andrew Drechsler, Provention Bio’s Chief Financial Officer will provide a corporate update at the H.C. Wainwright Global Life Sciences Conference.\u00a0 The webcast will be available beginning Tuesday, March 9, 2021, at 7:00 am E.T and can be accessed by visiting the Events and Webcasts section of the Company’s website: http:\/\/investors.proventionbio.com\/events. Oppenheimer & Co. 31st Annual Healthcare Conference Additionally, the company announced that Ashleigh Palmer, Provention Bio’s Chief Executive Officer and Co-Founder will participate in a fireside … Continue reading \"Provention Bio to Present at Two Upcoming Virtual Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-04T12:33:33+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/720849\/Provention_Bio_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Provention Bio to Present at Two Upcoming Virtual Investor Conferences","datePublished":"2021-03-04T12:33:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/"},"wordCount":421,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/720849\/Provention_Bio_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/","name":"Provention Bio to Present at Two Upcoming Virtual Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/720849\/Provention_Bio_Logo.jpg","datePublished":"2021-03-04T12:33:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/720849\/Provention_Bio_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/720849\/Provention_Bio_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/provention-bio-to-present-at-two-upcoming-virtual-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Provention Bio to Present at Two Upcoming Virtual Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=450501"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450501\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=450501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=450501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=450501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}